CN106310022A - Pelvic inflammatory disease diminishing preparation - Google Patents

Pelvic inflammatory disease diminishing preparation Download PDF

Info

Publication number
CN106310022A
CN106310022A CN201610976804.4A CN201610976804A CN106310022A CN 106310022 A CN106310022 A CN 106310022A CN 201610976804 A CN201610976804 A CN 201610976804A CN 106310022 A CN106310022 A CN 106310022A
Authority
CN
China
Prior art keywords
parts
inflammatory disease
diminishing
preparation
pelvic inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610976804.4A
Other languages
Chinese (zh)
Inventor
陈红侠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610976804.4A priority Critical patent/CN106310022A/en
Publication of CN106310022A publication Critical patent/CN106310022A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a pelvic inflammatory disease diminishing preparation. The pelvic inflammatory disease diminishing preparation is prepared from the following raw materials in parts by weight: 50-70 parts of radix scutellariae, 20-40 parts of herba patriniae, 10-30 parts of salviae miltiorrhizae radix et rhizoma, 10-30 parts of fructus forsythiae, 10-20 parts of cortex moutan, 10-20 parts of red peony roots, 10-20 parts of coix seeds, 10-20 parts of placenta hominis, 10-20 parts of fluorite, 50-70 parts of semen cuscutae, 20-30 parts of wolfberry fruits and 10-30 parts of radix rehmanniae preparata. According to the pelvic inflammatory disease diminishing preparation, various types of traditional Chinese medicines are reasonably and scientifically matched; and a lot of clinical researches show that the pelvic inflammatory disease diminishing preparation has no toxic or side effects and has the advantages of short treatment course, rapid curative effect, thorough treatment and no recurrence.

Description

Pelvic inflammation disappears
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of pelvic inflammation and disappear.
Background technology
Pelvic inflammatory disease is a kind of common gynaecopathia, and sickness rate is high, it is difficult to radical cure, the most repeatedly, currently without preferably Prescription to the ill.
Summary of the invention
According to above-mentioned elaboration, it is an object of the invention to provide a kind of clinical efficacy notable, effect is obvious, it is possible to effectively control Treat the prescription of pelvic inflammatory disease.
The technical scheme that the present invention provides: pelvic inflammation disappears, and is to be prepared by the raw materials in:
Radix Scutellariae 50～70 parts, Herba Patriniae 20～40 parts, Radix Salviae Miltiorrhizae 10～30 parts, Fructus Forsythiae 10～30 parts, Cortex Moutan 10～20 parts, red Chinese herbaceous peony 10～20 parts, Semen Coicis 10～20 parts, Placenta Hominis 10～20 parts, Fluoritum 10～20 parts, Semen Cuscutae 50～70 parts, Fructus Lycii 20 ～30 parts, thermally 10～30 parts.
In technique scheme, it is to be prepared by the raw materials in:
Radix Scutellariae 60 parts, Herba Patriniae 30 parts, Radix Salviae Miltiorrhizae 20 parts, Fructus Forsythiae 20 parts, Cortex Moutan 15 parts, Radix Paeoniae Rubra 15 parts, Semen Coicis 15 parts, purple river 15 parts of car, Fluoritum 15 parts, Semen Cuscutae 60 parts, Fructus Lycii 25 parts, thermally 20 parts.
The various drug matching of the present invention is reasonable, science, through a large amount of clinical verifications, no side effects, has short treating period, treatment Effect quickly, thorough treatment, the advantage that do not recurs, effective percentage reaches 89.7%, and its manufacture method is simple, and raw material is easy to get, and good effect, Instant effect, low cost.
Detailed description of the invention
Below technical scheme is clearly and completely described, it is clear that described embodiment is only this Invent a part of embodiment rather than whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art exist Do not make the every other embodiment obtained under creative work premise, broadly fall into the scope of protection of the invention.
It is to be prepared by the raw materials in that the pelvic inflammation that the present invention provides disappears:
Radix Scutellariae 50～70 parts, Herba Patriniae 20～40 parts, Radix Salviae Miltiorrhizae 10～30 parts, Fructus Forsythiae 10～30 parts, Cortex Moutan 10～20 parts, red Chinese herbaceous peony 10～20 parts, Semen Coicis 10～20 parts, Placenta Hominis 10～20 parts, Fluoritum 10～20 parts, Semen Cuscutae 50～70 parts, Fructus Lycii 20 ～30 parts, thermally 10～30 parts.
The open following example of the present invention.
Embodiment 1:
Pelvic inflammation disappears, and is to be prepared by the raw materials in:
Radix Scutellariae 50 parts, Herba Patriniae 20 parts, Radix Salviae Miltiorrhizae 10 parts, Fructus Forsythiae 10 parts, Cortex Moutan 10 parts, Radix Paeoniae Rubra 20 parts, Semen Coicis 20 parts, purple river 20 parts of car, Fluoritum 20 parts, Semen Cuscutae 70 parts, Fructus Lycii 30 parts, thermally 30 parts.
Embodiment 2:
Pelvic inflammation disappears, and is to be prepared by the raw materials in:
Radix Scutellariae 70 parts, Herba Patriniae 40 parts, Radix Salviae Miltiorrhizae 30 parts, Fructus Forsythiae 30 parts, Cortex Moutan 20 parts, Radix Paeoniae Rubra 10 parts, Semen Coicis 10 parts, purple river 10 parts of car, Fluoritum 10 parts, Semen Cuscutae 50 parts, Fructus Lycii 20 parts, thermally 10 parts.
Embodiment 3:
Pelvic inflammation disappears, and is to be prepared by the raw materials in:
Radix Scutellariae 60 parts, Herba Patriniae 30 parts, Radix Salviae Miltiorrhizae 20 parts, Fructus Forsythiae 20 parts, Cortex Moutan 15 parts, Radix Paeoniae Rubra 15 parts, Semen Coicis 15 parts, purple river 15 parts of car, Fluoritum 15 parts, Semen Cuscutae 60 parts, Fructus Lycii 25 parts, thermally 20 parts.
Method of administration: oral, three times on the one, each 6g, warm water clothes send, within one month, are a course for the treatment of.
Taboo: ban on opium-smoking and the opium trade, wine, pungent, raw and cold product, not depression, is not taken by pregnant women.
Function introduction: eliminating stagnation of regulating the flow of vital energy, blood stasis dispelling eliminating mass.For hysteromyoma ovarian cyst, hydrosalpinx, fallopian tube is not Logical, and pelvic inflammatory disease, adnexitis, metritis, also the kidney invigorating and essence nourishing, to adjust punching to help ovum, wed for women the most infertile, lower abdomen is sent out cool, The light film of libido, soreness of the waist and knees, the few color of delayed menstrual cycle amount is light waits disease.
Typically taking medicine three days and take effect, severe patient takes effect for 7 days, and general needs to fully recover one or two course for the treatment of.
For showing the application effect of the present invention, the present invention proves through clinical and experimental study:
1, certain female 42 years old, hysteromyoma ovarian cyst, pelvic inflammation, after taking this medicine, remission on the 3rd, patient's pain Hardship alleviates, continuous use three times, transference cure.
2, certain female 31 years old, hydrosalpinx, obstruction of fallopian tube, transference cure after one course for the treatment of of medication.
3, certain female 36 years old, has pelvic inflammatory disease, adnexitis, metritis simultaneously, takes medicine 15 days, hence it is evident that transference cure.
This medicine treats above-mentioned hysteromyoma ovarian cyst, hydrosalpinx, obstruction of fallopian tube, and pelvic inflammatory disease, adnexa altogether Inflammation, patient 248 example of metritis etc., cured person 112 example after treating seven days, cured person 109 example after treating 15, effective percentage It is 89.7%.
The above, the only detailed description of the invention of the present invention, but protection scope of the present invention is not limited thereto, and any Those familiar with the art, in the technical scope that the invention discloses, can readily occur in change or replace, should contain Cover within protection scope of the present invention.Therefore, protection scope of the present invention should described be as the criterion with scope of the claims.

Claims (2)

1. pelvic inflammation disappears, it is characterised in that: be to be prepared by the raw materials in:
Radix Scutellariae 50～70 parts, Herba Patriniae 20～40 parts, Radix Salviae Miltiorrhizae 10～30 parts, Fructus Forsythiae 10～30 parts, Cortex Moutan 10～20 parts, Radix Paeoniae Rubra 10 ～20 parts, Semen Coicis 10～20 parts, Placenta Hominis 10～20 parts, Fluoritum 10～20 parts, Semen Cuscutae 50～70 parts, Fructus Lycii 20～30 Part, thermally 10～30 parts.
2. pelvic inflammation as claimed in claim 1 disappears, it is characterised in that: be to be prepared by the raw materials in:
Radix Scutellariae 60 parts, Herba Patriniae 30 parts, Radix Salviae Miltiorrhizae 20 parts, Fructus Forsythiae 20 parts, Cortex Moutan 15 parts, Radix Paeoniae Rubra 15 parts, Semen Coicis 15 parts, Placenta Hominis 15 Part, Fluoritum 15 parts, Semen Cuscutae 60 parts, Fructus Lycii 25 parts, thermally 20 parts.
CN201610976804.4A 2016-11-07 2016-11-07 Pelvic inflammatory disease diminishing preparation Pending CN106310022A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610976804.4A CN106310022A (en) 2016-11-07 2016-11-07 Pelvic inflammatory disease diminishing preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610976804.4A CN106310022A (en) 2016-11-07 2016-11-07 Pelvic inflammatory disease diminishing preparation

Publications (1)

Publication Number Publication Date
CN106310022A true CN106310022A (en) 2017-01-11

Family

ID=57816120

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610976804.4A Pending CN106310022A (en) 2016-11-07 2016-11-07 Pelvic inflammatory disease diminishing preparation

Country Status (1)

Country Link
CN (1) CN106310022A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634364A (en) * 2004-11-22 2005-07-06 苟文丽 Enema for treating pelvic inflammation and other disease
CN105749037A (en) * 2016-03-30 2016-07-13 宜都市中医医院 Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof
CN106038979A (en) * 2016-07-05 2016-10-26 张阳 Medicinal liquid for acupuncture for treating ovulation failure and preparation method of medicinal liquid for acupuncture for treating ovulation failure

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634364A (en) * 2004-11-22 2005-07-06 苟文丽 Enema for treating pelvic inflammation and other disease
CN105749037A (en) * 2016-03-30 2016-07-13 宜都市中医医院 Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof
CN106038979A (en) * 2016-07-05 2016-10-26 张阳 Medicinal liquid for acupuncture for treating ovulation failure and preparation method of medicinal liquid for acupuncture for treating ovulation failure

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
孙少霞: ""活血化瘀、清热利湿法治疗慢性盆腔炎100例"", 《江西中医药》 *

Similar Documents

Publication Publication Date Title
CN103386086A (en) Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof
CN104474371A (en) Traditional Chinese medicine for treating impotence
CN104544586A (en) Healthcare underwear for preventing and treating women dysmenorrhea
CN102961483B (en) Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof
CN102526635B (en) Medicament for treating premenstrual stress syndrome and preparation method thereof
CN103919966B (en) A kind of medicine treating acne
CN102225118B (en) Blood-activating wind-dispelling liquid
CN106310022A (en) Pelvic inflammatory disease diminishing preparation
CN104107280A (en) Pharmaceutical composition for treating chronic pelvic inflammation, and preparation method and application thereof
CN103830591A (en) Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine
CN102935209A (en) Traditional Chinese medicinal preparation for treating hyperplasia of mammary glands
CN102949507B (en) Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof
CN105521175A (en) Traditional Chinese medicine for treating blood stasis type hypomenorrhea
CN105169253A (en) Traditional Chinese medicine decoction for treating amenorrhea
CN102861227B (en) Traditional Chinese medicine composition for treating suppurative meningitis sequelae and preparation method of traditional Chinese medicine composition
CN103127295B (en) One is treated leukemic Chinese medicine
CN105232977A (en) External use medicine for treating gynecologic inflammation
CN105343803A (en) Traditional Chinese medicine ointment for treating gynecological inflammation
CN105709195A (en) Traditional Chinese medicine paste for preventing and treating PICC phlebitis and phlebothrombosis
CN105596471A (en) Pills for treating stroke caused by phlegm-stasis blocking collateral and preparation method
CN104491777A (en) Medicine for treating dermatitis and preparation method of medicine
CN105012871A (en) Traditional Chinese medicine for removing freckles and beautifying and preparation method of traditional Chinese medicine
CN104524331B (en) Prevent the drug of mumps
CN104257992A (en) Traditional Chinese medicine composition for treating dysmenorrhea of women
CN103566308A (en) Traditional Chinese medicine for treating primary dysmenorrhea

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170111